Aquestive Therapeutics, Inc. (AQST) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGM. Market cap 597.44M USD. 52-week range 2.93 to 7.55 USD. Data as of 2026-10-09.
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of ...